Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,552 | 87,288 | 25,373 | 0 | 0 |
| Marketable Securities | 22,841 | N/A | N/A | 0 | 0 |
| Receivables | 3,121 | 2,943 | 537 | 0 | 0 |
| TOTAL | $79,738 | $92,059 | $26,959 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,070 | 1,164 | 1,264 | N/A | N/A |
| Other Non-Current Assets | 251 | 256 | 3,327 | 0 | 0 |
| TOTAL | $1,321 | $1,420 | $4,591 | $N/A | $N/A |
| Total Assets | $81,059 | $93,479 | $31,550 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 982 | 3,470 | 2,011 | 0 | 0 |
| Accrued Expenses | 4,629 | 4,464 | 4,646 | 0 | 0 |
| Other current liabilities | 223 | 223 | 217 | 0 | 0 |
| TOTAL | $5,834 | $8,157 | $6,874 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 327 | 371 | 407 | 594 | 535 |
| TOTAL | $327 | $365 | $399 | $N/A | $N/A |
| Total Liabilities | $6,161 | $8,522 | $7,273 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,378 | 14,369 | 14,369 | N/A | N/A |
| Common Shares | 14 | 14 | N/A | 0 | 0 |
| Retained earnings | -107,484 | -96,840 | -82,194 | 0 | 0 |
| Other shareholders' equity | 326 | 355 | 106,471 | 0 | 0 |
| TOTAL | $74,898 | $84,957 | $24,277 | $0 | $0 |
| Total Liabilities And Equity | $81,059 | $93,479 | $31,550 | $0 | $0 |